Key Takeaways

• Bernstein maintains Outperform rating on Microsoft (MSFT) with $641 price target
• Shares have declined 27.5% in the past six months, hovering near the 52-week low of $370.87
• Analyst cites temporary Azure margin compression linked to timing mismatch between AI infrastructure investment and revenue generation
• Azure revenue growth projected to gain momentum in Q3 with sustained strength through Q4
• 34 of 37 Wall Street analysts rate MSFT a Buy, with consensus price target at $581.61

Microsoft shares have endured a punishing six-month stretch, shedding 27.5% of their value to reach $370.87. The stock now hovers dangerously close to its 52-week nadir. Yet Bernstein remains firmly in the bull camp.

Microsoft Corporation, MSFT

Mark Moerdler, an analyst at Bernstein, has reaffirmed his Outperform rating alongside a $641 price objective on MSFT — representing potential upside exceeding 70% from current trading levels.

Bernstein’s thesis hinges on a critical timing mismatch. Microsoft has been aggressively investing in artificial intelligence infrastructure, a strategy that has spooked certain market participants. However, Moerdler contends the capital deployment isn’t the red flag many perceive.

The research firm’s analysis suggests that the majority of this capital expenditure flows into infrastructure capacity that begins producing revenue within a six-month window following deployment. This temporal gap between outlay and returns is creating unfavorable optics in the near term.

Bernstein dissected five potential allocation channels for Microsoft’s capital expenditures: proprietary applications, complimentary Copilot access, internal operations, lower-margin Azure AI revenue streams, and capacity awaiting activation. The firm’s findings paint a more constructive picture than current market sentiment reflects.

A substantial portion of investment is directed toward higher-margin business segments, especially Microsoft’s proprietary software and AI solutions. Copilot, in particular, is generating SaaS-quality AI revenue with healthy margins after transitioning to a paid subscription model.

Azure Margins Under Pressure — But Not Forever

Azure’s margin profile has experienced compression, a reality Bernstein openly acknowledges. The driving force, according to the firm, stems from nascent AI workloads carrying thinner margins compared to conventional cloud services.

As these workloads evolve and achieve scale, Bernstein anticipates margin improvement. The current pressure reflects Azure’s position within its AI expansion trajectory rather than indicating a fundamental flaw.

Research and development expenditure as a proportion of total revenue has remained essentially stable. Bernstein leverages this data point to demonstrate that Microsoft maintains capital discipline rather than spending recklessly.

Microsoft delivered 16.7% revenue expansion over the trailing twelve months. The stock currently trades at a P/E multiple of 23.26, accompanied by a PEG ratio of 0.8 — metrics that both Bernstein and InvestingPro characterize as undervalued relative to present price levels.

Azure Growth Expected to Pick Up in Second Half

Bernstein projects Azure growth acceleration commencing in Q3, with sustained positive momentum extending into Q4. This forecast directly correlates with previously funded capacity transitioning to active revenue-generating status.

Microsoft has simultaneously embarked on an initiative to develop proprietary large-scale AI models by 2027, positioning them as alternatives to solutions from OpenAI and Anthropic.

UBS recently reaffirmed a Buy rating on Chevron following announcement of a power generation partnership with Microsoft. The collaboration involves constructing natural gas facilities in Texas specifically designed to supply electricity to Microsoft’s AI data center infrastructure.

Across Wall Street, 34 of 37 analysts covering MSFT over the past three months assigned Buy ratings. The consensus price target stands at $581.61, suggesting 56% appreciation potential from present levels.